Abstract
CONFIRMING inflammatory bowel disease (IBD) in dogs, which is often idiopathic, can be difficult and continues to confound in achieving a definitive diagnosis in dogs presenting with chronic enteropathies. It...
Highlights
Confirming inflammatory bowel disease (IBD) in dogs can be difficult and continues to confound in achieving a definitive diagnosis in dogs presenting with chronic enteropathies (CE)
This emphasised the importance of a systematic diagnostic approach, in attempting to identify both food and antibiotic responsive enteropathies
It is important that trial therapy, if it is introduced, has minimal side-effects which could lead to clinical deterioration or perhaps more worryingly to owners withdrawing treatment based on welfare grounds
Summary
Problems arise in dogs that have less severe disease where the results of diagnostic investigations may be more equivocal. Serological and faecal biomarkers which are used extensively in humans for the diagnosis and management of IBD (Lopez et al 2016, Kochhar and Lashner 2017) are of limited availability in dogs and our ability to interpret any results is imperfect (Jergens et al 2010, Grellet et al 2014). In addition to the difficulties over diagnostic approaches and therapeutic decision-making in dogs with CE, clinical responses can vary (Craven et al 2004, Allenspach et al 2007, Garcia-Sancho et al 2007).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
